It has been reported that ACE2 expression, a SARS-CoV-2 receptor, decreases with infection in peripheral tissues and this may lead to a decrease in GLUT4 expression, which ultimately develops insulin resistance [14,15]. The gene discussed is SLC2A4; the disease is Insulin resistance.